TCL Archive DCT Board Approves Concept Of Contract Recompetitions Worth $5.1 Million A Year July 10, 1981
TCL Archive DCT Board Okays Contract Recompetitions, But Litton Bionetics May Be Barred From Two Supporting Gall’s Lab, Plus FCRF Program November 1, 1985
TCL Archive Decision To Stop NSABP P-4 Study Before It Starts Shocks Clinical Trialists. March 2, 2007